Product category:
Proteomics
News Release from: Bruker Daltonics | Subject: Ibis T5000
Edited by the Laboratorytalk Editorial
Team on 04 October 2006
Universal biosensor system highlighted
at ICAAC
Ibis T5000 is a breakthrough universal biosensor that supports the rapid identification, characterisation and quantification of a broad range of bacteria, viruses and fungi in virtually any sample
Isis Pharmaceuticals reports that scientists from its Ibis Biosciences (Ibis) division and collaborators presented the results of five diverse studies emphasizing the importance and breadth of applications of the Ibis biosensor technology and the Ibis T5000 biosensor system in identifying and characterising infectious organisms The studies were presented at the 46th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held this week in San Francisco, CA, which hosted more than 10,000 attendees comprising physicians, clinicians and researchers working in the fields of clinical diagnostics, drug discovery and microbiology
This article was originally published on Laboratorytalk on 5 Oct 2006 at 8.00am (UK)
Related stories
First commercial order for Ibis T5000 biosensor
Systems will be used by initial customer for high-throughput forensic analysis of human mitochondrial DNA (mtDNA) to genotype and identify individuals based on unique patterns of genetic variation
European introduction of the Ibis T5000 biosensor
Bruker Daltonics and Isis Pharmaceuticals announced the European introduction of the Ibis T5000 biosensor system for the identification and characterisation of microorganisms
The Ibis T5000 is a breakthrough universal biosensor system that supports the rapid and efficient identification, characterisation and quantification of a broad range of bacteria, viruses and fungi in virtually any sample without prior knowledge of what organisms may be present.
The system does not require time- and labour-intensive steps such as sequencing or culture, and it can be used to obtain high-resolution genotypes of organisms in a rapid, high- throughput manner.
The Ibis T5000 biosensor system has been extensively validated for a number of assays and is being commercialized by Ibis and its partner, Bruker Daltonics.
Further reading
Agreement covers Ibis T5000 biosensor system
Ibis T5000 is a universal biosensor that can simultaneously identify thousands of types of infectious organisms in a sample, without needing to know beforehand what might be present in the sample
Revolutionary ultra-high resolution TOF mass spec
At ASMS 2008, Bruker Daltonics announced the Maxis, a revolutionary new electrospray ultra-high resolution tandem TOF (UHR-Qq-TOF) mass spectrometer
Commenting on the ICAAC presentations, David Ecker, chief scientific officer of Ibis Biosciences and vice president of Isis, said, "We are very pleased with the breadth of data presentations included at this meeting.
"The studies highlighted exemplify the substantial contribution the Ibis T5000 biosensor system can make in the identification and characterisation of infectious organisms in broad applications, from epidemiologic surveillance to identifying and preventing hospital-acquired infections, and eventually to disease diagnostics.
"As we begin to commercialize our Ibis biosensor technology, the opportunity to display its capabilities, with the strong support of our collaborators, to the broader infectious disease community is invaluable".
A summary of the presentations follows: An MLST Schema and Rapid MLST Analysis Strategy for Molecular Genotyping of Acinetobacter baumannii for Infection Control.
Acinetobacter infections are frequent complications of wound infections and have been particularly problematic in military personnel injured in Iraq.
The Ibis T5000 biosensor system rapidly identified and characterised with regard to virulence and drug resistance factors, Acinetobacter organisms in more than 267 samples from infected soldiers.
The method required less than four hours to provide genotypic identification of the Acinetobacter strain types that caused the infections.
Such information was used to determine that the source of the infection was hospital-based, disproving the initial hypothesis that the infections were soil-based, and allowed appropriate steps to be taken to reduce the incidence of future infections. Request a free brochure from Bruker Daltonics ...
• Bruker Daltonics: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
